ICD-10-CM Billable Code

N01.9

Rapidly progressive nephritic syndrome with unspecified morphologic changes

Clinical Classification Guidelines

Medical Intelligence & Overview

Rapidly progressive nephritic syndrome (RPGN) is a serious kidney condition characterized by sudden and swift deterioration of kidney function. When classified under ICD-10 code N01.9, it indicates a form of nephritic syndrome where the exact structural changes in the kidneys are unspecified, but the rapid progression poses significant health risks. Recognizing this condition early is crucial as it can lead to kidney failure if not treated promptly. This overview provides an accessible explanation aimed at patients and their families, outlining causes, symptoms, diagnostic approaches, and treatment options.

Causes & Symptoms

Clinical Causes: Autoimmune diseases such as Goodpasture's syndrome or lupus erythematosus Vasculitis, which involves inflammation of blood vessels in the kidneys Post-infectious glomerulonephritis following infections like strep throat Certain drugs and toxins that may damage kidney tissues Progression of other chronic kidney diseases

Key Symptoms: Blood in the urine (hematuria), leading to pink or cola-colored urine Reduced or decreased urine output Swelling in the legs, ankles, or around the eyes (edema) High blood pressure (hypertension) Fatigue and general feeling of weakness Fever and malaise in some cases Nausea and loss of appetite Back or flank pain

Diagnostic & Treatment

Diagnosis Path: Diagnosing rapidly progressive nephritic syndrome involves a combination of medical history assessment, physical examinations, and laboratory tests. Key diagnostic steps include: - Blood tests to evaluate kidney function (such as serum creatinine and blood urea nitrogen) - Urinalysis to detect presence of blood, protein, and cellular elements - Imaging studies like ultrasound to assess kidney size and structure - Kidney biopsy, which is critical for definitive diagnosis—although in cases with unspecified morphological changes, the biopsy results may be inconclusive regarding specific structural abnormalities - Serological tests to identify underlying autoimmune or infectious causes Early and precise diagnosis is essential for initiating appropriate treatment and preventing irreversible kidney damage.

Treatment Protocols: Treatment strategies for rapidly progressive nephritic syndrome focus on controlling inflammation, managing symptoms, and addressing underlying causes. Approaches may include: - Immunosuppressive medications such as corticosteroids and other agents to reduce immune response - Plasmapheresis (plasma exchange) in certain cases to remove harmful antibodies - Blood pressure medications, including ACE inhibitors or ARBs, to protect kidney function - Antibiotics if an infection is identified as the trigger - Dialysis in advanced cases where kidney failure occurs Treatment plans are tailored based on individual patient conditions and the severity of the disease. Early intervention significantly improves the prognosis and can slow or halt disease progression.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N01.9 a billable ICD-10 code?
Yes, N01.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N01.9?
Clinical documentation must specify the nature of Rapidly progressive nephritic syndrome with unspecified morphologic changes and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

rapidly syndrome progressive nephritic morphologic changes